|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.9 TWD | +0.85% |
|
+1.13% | +8.48% |
Allied Biotech Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 716.75 million compared to TWD 676.76 million a year ago. Net income was TWD 146.74 million compared to TWD 13.04 million a year ago.
Basic earnings per share from continuing operations was TWD 1.54 compared to TWD 0.14 a year ago. Diluted earnings per share from continuing operations was TWD 1.53 compared to TWD 0.14 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.48% | 52.56M | |
| +8.20% | 7.78B | |
| +0.34% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
ALLIED BIOTECH CORPORATION 
